Volume | 0 |
|
|||||
News | - | ||||||
Day High | Low High |
||||||
Day Low |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Alpine Income Property Trust Inc | PINE | NYSE | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
14.93 |
Trades | Volume | Avg Volume | 52 Week Range |
---|---|---|---|
0 | 0 | - | 14.25 - 17.76 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
- | 0 | $ 14.93 | USD |
Alpine Income Property Trust Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
203.05M | 13.62M | - | 45.64M | 2.92M | 0.21 | 69.61 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Alpine Income Property News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PINE Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 15.37 | 15.45 | 14.80 | 14.96 | 37,066 | -0.44 | -2.86% |
1 Month | 15.35 | 15.50 | 14.325 | 15.05 | 52,713 | -0.42 | -2.74% |
3 Months | 15.11 | 16.13 | 14.325 | 15.38 | 55,622 | -0.18 | -1.19% |
6 Months | 15.32 | 17.6799 | 14.325 | 15.90 | 56,444 | -0.39 | -2.55% |
1 Year | 16.05 | 17.76 | 14.25 | 16.00 | 71,150 | -1.12 | -6.98% |
3 Years | 18.41 | 21.069 | 14.25 | 17.66 | 72,858 | -3.48 | -18.90% |
5 Years | 19.00 | 21.069 | 7.56 | 17.09 | 69,670 | -4.07 | -21.42% |
Alpine Income Property Description
Alpine Immune Sciences Inc is a clinical-stage biopharmaceutical company. It is engaged in discovering and developing innovative, protein-based immunotherapies to treat cancer and autoimmune and inflammatory diseases. The company's proprietary scientific platform uses a process known as directed evolution to create therapeutics capable of modulating human immune system proteins. Its product pipeline includes ALPN-101 and ALPN-202. |